Next Article in Journal
Comparative Study on Inhibitory Activity of Zerumbone and Zerumbone 2,3-Epoxide on NF-κB Activation and NO Production
Previous Article in Journal
Preparation and Biological Evaluation of a [55Co]-2-Acetylpyridine Thiosemicarbazone
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Isolation and Characterization of a Trace Level Unknown Impurity of Salmeterol by Chromatographic and Spectroscopic Methods

by
Bandaru VENKATASUBBAIAH
1,*,
Lakki Reddy PRAKASH
1,
Rudraraju Vasu DEV
2,
Vakamudi VARAPRASAD
3 and
Kalluru SUBRAMANYAM REDDY
4
1
Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad-500 072, India
2
Analytical Research, Discovery Research, Dr. Reddy’s Laboratories Ltd., Miyapur, Hyderabad-500 049, India
3
Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad-500 072, India
4
Department of Chemistry, Sri Venkateswara University, Tirupati-517 502, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(3), 579-588; https://doi.org/10.3797/scipharm.0906-01
Submission received: 1 June 2009 / Accepted: 2 July 2009 / Published: 4 July 2009

Abstract

During the process development of Salmeterol, an unknown impurity was detected at 2.08 Relative Retention Time (RRT) at a level of 0.11% by a gradient Reverse Phase-High Performance Liquid Chromatography (RP-HPLC). The impurity was isolated from the salmeterol drug substance using preparative HPLC. The separation was achieved with an Inertsil C8 column, using acetonitrile–trifluroacetic acid buffer pH 2.7 as mobile phase. The isolated impurity was characterized by NMR and MS techniques. The impurity has been characterized as 4-(2-{[6-(4-cyclohexylbutoxy)hexyl]amino}-1-hydroxyethyl)- 2-(hydroxymethyl)phenol. The synthesis of the impurity and its formation was also discussed.
Keywords: Salmeterol Impurity; Preparative HPLC; Spectroscopy; Isolation; Identification and Characterization Salmeterol Impurity; Preparative HPLC; Spectroscopy; Isolation; Identification and Characterization

Share and Cite

MDPI and ACS Style

VENKATASUBBAIAH, B.; PRAKASH, L.R.; DEV, R.V.; VARAPRASAD, V.; SUBRAMANYAM REDDY, K. Isolation and Characterization of a Trace Level Unknown Impurity of Salmeterol by Chromatographic and Spectroscopic Methods. Sci. Pharm. 2009, 77, 579-588. https://doi.org/10.3797/scipharm.0906-01

AMA Style

VENKATASUBBAIAH B, PRAKASH LR, DEV RV, VARAPRASAD V, SUBRAMANYAM REDDY K. Isolation and Characterization of a Trace Level Unknown Impurity of Salmeterol by Chromatographic and Spectroscopic Methods. Scientia Pharmaceutica. 2009; 77(3):579-588. https://doi.org/10.3797/scipharm.0906-01

Chicago/Turabian Style

VENKATASUBBAIAH, Bandaru, Lakki Reddy PRAKASH, Rudraraju Vasu DEV, Vakamudi VARAPRASAD, and Kalluru SUBRAMANYAM REDDY. 2009. "Isolation and Characterization of a Trace Level Unknown Impurity of Salmeterol by Chromatographic and Spectroscopic Methods" Scientia Pharmaceutica 77, no. 3: 579-588. https://doi.org/10.3797/scipharm.0906-01

Article Metrics

Back to TopTop